PARP inhibitor
Our blog features information and personal perspectives on topics of interest to the hereditary cancer community.Stay up to date on research and information
Sign Up for FORCE NewslettersDecember 12, 2012
Clinical Trials for Hereditary Cancer: Where the Rubber Meets the Road
Posted in:
Research
Tags:
BRCA ,
Breast Cancer ,
Hereditary Cancer Research ,
BRCA1 ,
BRCA2 ,
FDA ,
Clinical Trials ,
PARP Inhibitor
October 12, 2017
Patients Weigh In On Review of PARP Inhibitors for Treatment of Ovarian Cancer
Posted in:
Laws, Protections And Public Policy ,
Cancer Treatment
Tags:
Ovarian Cancer ,
PARP Inhibitor ,
Patient Advocacy
April 12, 2018
PARP Inhibitors and Hereditary Cancer: What’s New?
Posted in:
Research ,
Cancer Treatment
Tags:
BRCA ,
Ovarian Cancer ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
PALB2 ,
Pancreatic Cancer ,
ATM ,
Gene Panel Testing ,
Metastatic Breast Cancer ,
Ovarian Cancer Treatment ,
PARP Inhibitor ,
Cancer Research ,
Advanced Breast Cancer ,
Inherited Mutations ,
Prostate Cancer Treatment ,
Metastatic Prostate Cancer ,
Cancer Targeted Therapy
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.
November 19, 2019
FORCE Launches the New XRAY-Ovarian Cancer Program
Posted in:
XRAY
Tags:
Hereditary Cancer ,
Ovarian Cancer ,
PARP Inhibitor ,
Cancer Research
January 06, 2020
New PARP Inhibitor Approval for Pancreatic Cancer
Posted in:
XRAY ,
Cancer Treatment
Tags:
Pancreatic Cancer ,
PARP Inhibitor ,
Pancreatic Cancer Treatment ,
Hereditary Pancreatic Cancer
August 24, 2020
PARP Inhibitor Treatment Is Helping My Pancreatic Cancer
Posted in:
Stories
Tags:
BRCA1 ,
Pancreatic Cancer ,
PARP Inhibitor ,
Pancreatic Cancer Treatment ,
Men With Mutations